NEW YORK CITY

Genzyme Shares Hit New High as Board Recommends Sanofi's Revised Offer

A sign marks the headquarters of Genzyme in Cambridge
Shares of Genzyme Corp. (NASDAQ: GENZ) touched a new 52-week high of $75.90 on Monday. The biotechnology firm's board has unanimously recommended to its shareholders to accept the latest sweetened offer from French drug giant Sanofi-Aventis SA (NYSE: SNY) and to tender their shares into the revised offer.
Tomotherapy Hi Art

TomoTherapy Shares Hit New High On Accuray Merger

Shares of TomoTherapy Inc. (NASDAQ: TOMO) touched a new 52-week high of $4.70 on Monday after it agreed to be acquired by Accuray Inc. (NASDAQ: ARAY) for $4.80 a share in cash and stock or a total of about $277 million.
More news
Taiwan AIG unit bidders set to face regulators

Taiwan AIG unit bidders set to face regulators

Shareholders of two of the firms in a consortium buying U.S. insurer AIG's Taiwan unit approved the $2.16 billion bid on Wednesday, setting the scene for what is expected to be a tough battle with regulators.
A man leans against a wall to read his newspaper before entering the subway in Grand Central Station in New York

Manhattan loses jobs as outer boroughs grow: study

Manhattan lost nearly 110,000 jobs from 2000 to 2009 while its outer boroughs were gaining jobs, thanks to the growth of two sectors, education and healthcare, a think tank's report said on Wednesday.
A pedestrian walks past the NASDAQ building in New York City

Nasdaq mulls NYSE bid in exchange deal dash

Nasdaq OMX Group Inc could launch a rival bid for NYSE Euronext to avoid being left on the sidelines, a source said, as traditional exchanges race to merge to see off upstart electronic rivals.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.